Overexpression of Toll-Like Receptor 3 in Spleen is Associated with Experimental Arthritis in Rats

Scandinavian Journal of Immunology

Volumn 76, Issue 3, 2012, Pages 263-270

  Zhu, W ^a   Meng, L ^a   Jiang, C ^a   Xu, J ^a   Wang, B ^a   Han, Y ^a   Lu, S ^a,b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; MESSENGER RNA; METHOTREXATE; PHYTOL; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; IMMUNITY; IMMUNOREGULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; RATS; REAL-TIME POLYMERASE CHAIN REACTION; SPLEEN; TOLL-LIKE RECEPTOR 3; UP-REGULATION;

EID: 84865355650     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02724.x     Document Type: Article

References (37)

1. Arend WP. The innate immune system in rheumatoid arthritis. Arthritis Rheum 2001;44:2224-34.
2. Ji H, Ohmura K, Mahmood U et al. Arthritis critically dependent on innate immune system players. Immunity 2002;16:157-68.
3. Brentano F, Kyburz D, Schorr O, Gay R, Gay S. The role of toll-like receptor signalling in the pathogenesis of arthritis. Cell Immunol 2005;233:90-6.
4. O'Neill LA. Primer: toll-like receptor signaling pathways - what do rheumatologists need to know? Nat Clin Pract Rheumatol 2008;4:319-27.
5. Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity 2010;32:305-15.
6. Barton GM, Medzhitov R. Toll-like receptor signaling pathways. Science 2003;300:1524-5.
7. Liu HY, Komai-Koma M, Xu D, Liew FY. Toll-like receptor 2 signaling modulates the functions of CD4(+)CD25(+) regulatory T cells. Proc Natl Acad Sci U S A 2006;103:7048-53.
8. Herlands RA, Christensen SR, Sweet RA, Hershberg U, Shlomchik MJ. T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity 2008;29:249-60.
9. Abdollahi-Roodsaz S, Joosten LAB, Koenders MI et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008;118:205-16.
10. Ospelt C, Brentano F, Rengel Y et al. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum 2008;58:3684-92.
11. Brentano F, Schorr O, Gay RE, Gay S, Kyburz D. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll-like receptor 3. Arthritis Rheum 2005;52:2656-65.
12. Roelofs MF, Joosten LAB, Abdollahi-Roodsaz S et al. The Expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 2005;52:2313-22.
13. van der Heijden IM, Wilbrink B, Tchetverikov I et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum 2000;43:593-8.
14. Roelofs MF, Boelens WC, Joosten LAB et al. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 2006;176:7021-7.
15. Zhu WH, Meng LS, Jiang CS et al. Arthritis is associated with T-cell-induced upregulation of toll-like receptor 3 on synovial fibroblasts. Arthritis Res Ther 2011;13:R103.
16. Meng LS, Zhu WH, Jiang CS et al. Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats. Arthritis Res Ther 2010;12:R103.
17. Zhu WH, Meng LS, Jiang CS et al. Induction of toll-like receptor 2 positive antigen-presenting cells in spleen of pristane-induced arthritis in rats. Mol Biol Rep 2012;39:3667-73.
18. Hou W, Meng L, Tian L, Zhu W, Jiang C, Lu S. A systematic comparison between collagen-induced arthritis and pristane-induced arthritis in Dark Agouti rats. Clin Exp Rheumatol 2010;28:532-8.
19. Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R. Pristane-induced arthritis in rats - a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 1996;149:1675-83.
20. Hultqvist M, Olofsson P, Gelderman KA, Holmberg J, Holmdahl R. A new arthritis therapy with oxidative burst inducers. Plos Med 2006;3:1625-36.
21. Olofsson P, Nerstedt A, Hultqvist M et al. Arthritis suppression by NADPH activation operates through an interferon-β pathway. BMC Biol 2007;5:19.
22. Yrlid U, Milling SWF, Miller JL, Cartland S, Jenkins CD, MacPherson GG. Regulation of intestinal dendritic cell migration and activation by plasmacytoid dendritic cells, TNF-alpha and type 1 IFNs after feeding a TLR7/8 ligand. J Immunol 2006;176:5205-12.
23. Chan CW, Crafton E, Fan HN et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med 2006;12:207-13.
24. Redecke V, Hacker H, Datta SK et al. Cutting edge: activation of toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004;172:2739-43.
25. Abe M, Tokita D, Raimondi G, Thomson AW. Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses. Eur J Immunol 2006;36:2483-93.
26. Urry Z, Xystrakis E, Richards DF et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha, 25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest 2009;119:387-98.
27. Sutmuller RPM, den Brok M, Kramer M et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006;116:485-94.
28. Lee EK, Kang SM, Paik DJ, Kim JM, Youn J. Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS. Int Immunol 2005;17:325-33.
29. Roelofs MF, Wenink MH, Brentano F et al. Type I interferons might form the link between toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Ann Rheum Dis 2009;68:1486-93.
30. Iwahashi M, Yamamura M, Aita T et al. Expression of toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 2004;50:1457-67.
31. Huang QQ, Ma YY, Adebayo A, Pope RM. Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthritis Rheum 2007;56:2192-201.
32. Holmberg J, Tuncel J, Yamada H, Lu SM, Olofsson P, Holmdahl R. Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J Immunol 2006;176:1172-9.
33. Abdollahi-Roodsaz S, Joosten LAB, Helsen MM et al. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production. Arthritis Rheum 2008;58:3753-64.
34. Joosten LAB, Koenders MI, Smeets RL et al. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88. J Immunol 2003;171:6145-53.
35. Choe JY, Crain B, Wu SR, Corr M. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med 2003;197:537-42.
36. Ochaion A, Bar-Yehuda S, Cohn S et al. Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A(3) adenosine receptor expression. Arthritis Res Ther 2006;8:R169.
37. Hou W-k, Meng L-s, Zheng F et al. Methotrexate ameliorates pristane-induced arthritis by decreasing IFN-gamma and IL-17A expressions. J Zhejiang Univ Sci B 2011;12:40-6.